Nykode Therapeutics proposes chair of Zealand Pharma to lead own board

The board at Norwegian biotech firm Nykode Therapeutics, which is led by Danish CEO Michael Engsig, has proposed that the current Chairman at Zealand Pharma Martin Nicklasson also chairs the board at Nykode.

Martin Nicklasson, chair of Zealand Pharma, has been proposed as chair of Nykode Therapeutics | Photo: Zealand Pharma / PR

When Norwegian biotech firm Nykode Therapeutics meets for its general assembly on Dec. 22, a new face will join as chairman of the board of directors.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs